Mannkind (MNKD) Gross Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21,616.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -352.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -352.00 |
| Dec 31, 2025 | -618.00 |
| Sep 30, 2025 | -91.00 |
| Jun 30, 2025 | 172.00 |
| Mar 31, 2025 | 95.00 |
| Dec 31, 2024 | -4,028.00 |
| Sep 30, 2024 | 2,166.00 |
| Jun 30, 2024 | 2,106.00 |
| Mar 31, 2024 | 2,700.00 |
| Dec 31, 2023 | -3,846.00 |
| Sep 30, 2023 | 1,503.00 |
| Jun 30, 2023 | 151,020.00 |
| Mar 31, 2023 | 7,338.00 |
| Dec 31, 2022 | 33,608.00 |
| Sep 30, 2022 | -2,409.00 |
| Jun 30, 2022 | -152,005.00 |
| Mar 31, 2022 | -8,139.00 |
| Dec 31, 2021 | -24,380.00 |
| Sep 30, 2021 | 623.00 |
| Jun 30, 2021 | 181,955.00 |
| Mar 31, 2021 | 90.00 |
| Dec 31, 2020 | 916.00 |
| Sep 30, 2020 | 99,075.00 |
| Jun 30, 2020 | 32,500.00 |
| Mar 31, 2020 | -261.00 |
| Dec 31, 2019 | 214.00 |
| Sep 30, 2019 | -89,548.00 |
| Jun 30, 2019 | -203,262.00 |
| Mar 31, 2019 | 9,263.00 |
| Dec 31, 2018 | 7,967.00 |
| Sep 30, 2018 | 10,527.00 |
| Jun 30, 2018 | 10,426.00 |
| Mar 31, 2018 | -3,099.00 |
| Dec 31, 2017 | -7,684.00 |
| Sep 30, 2017 | -22,123.00 |